Journal ArticleOPEN ACCESS

New‐onset atypical fulminant type 1 diabetes after COVID‐19 vaccination: A case report

  • Kobayashi T
  • Yakou F
  • Saburi M
  • et al.
Clinical Case Reports (2022) 10(10)
DOI: 10.1002/ccr3.6473
N/ACitations
Citations of this article
12Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Adverse reactions, including the onset of diabetes, after coronavirus disease 2019 (COVID‐19) vaccination have been reported. Herein, we report a case of a man who developed anti‐glutamic acid decarboxylase (GAD) antibody‐positive fulminant type 1 diabetes 15 weeks after COVID‐19 vaccination, atypical of the previously reported anti‐GAD antibody‐negative cases.

Cite

CITATION STYLE

APA

Kobayashi, T., Yakou, F., Saburi, M., Hirose, A., Akaoka, H., Hirota, Y., … Matsushita, T. (2022). New‐onset atypical fulminant type 1 diabetes after COVID‐19 vaccination: A case report. Clinical Case Reports, 10(10). https://doi.org/10.1002/ccr3.6473

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free